Silvercrest Asset Management Group »

Travere Therapeutics shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.9M 104k 56.81

More positions owned by Silvercrest Asset Management Group

Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Cisco Systems (CSCO)
Alphabet Inc Class A cs (GOOGL)
Element Solutions (ESI)
SYNNEX Corporation (SNX)
Littelfuse (LFUS)
Delta Air Lines (DAL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Eaton (ETN)
BorgWarner (BWA)
Johnson & Johnson (JNJ)
Arcosa (ACA)

View all positions for Silvercrest Asset Management Group

Top funds holding Travere Therapeutics

Henderson Group
Jupiter Topco
BlackRock
FMR
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Perceptive Advisors
Nomura Asset Management International
Adage Capital Partners GP
Geode Capital Management
Rock Springs Capital Management
Armistice Capital
Kynam Capital Management
Stephens Investment Management Group

View all funds holding Travere Therapeutics